Overview
Abbott's neuromodulation division offers spinal cord stimulation, deep brain stimulation, and dorsal root ganglion therapies through products like the Proclaim DRG Neurostimulator and Infinity DBS system. Their BurstDR stimulation technology has been clinically shown to provide superior chronic pain relief compared to traditional tonic stimulation.
More in Neuromodulation
Latest industry news
It's Finally Here: FacialDx, an AI-Powered Support Tool for Sideline Concussion Assessments
2026-06-23 · Product
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 · Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 · Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 · Industry
Company details
Category
⚡ Neuromodulation
Location
Austin, TX, USA
Funding
NYSE: ABT
Website
abbott.com/neuromodulationListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →